B7-1(CD80) Fc Chimera, Human, 100ug

B7-1/CD80 and B7-2/CD86, together with their receptors CD28 and CTLA-4, constitute one of the dominant co-stimulatory pathways that regulate T- and B-cell responses. Although both CTLA-4 and CD28 can bind to the same ligands, CTLA-4 binds to B7-1 and B7-2 with a 20-100 fold higher affinity than CD28 and is involved in the down-regulation of the immune response. Mature human B7-1 consists of a 208 amino acid extracellular domain (ECD) with two immunoglobulin-like domains, a 21 amino acid transmembrane domain, and a 25 amino acid cytoplasmic domain. Both human and mouse B7-1 and B7-2 can bind to either human or mouse CD28 and sCTLA-4. B7-1 is expressed on activated B cells, activated T cells, and macrophages. B7-2 is constitutively expressed on interdigitating dendritic cells, Langerhans cells, peripheral blood dendritic cells, memory B cells, and germinal center B cells. Recombinant Human B7-1(CD80) Fc Chimera produced in HEK293 cells is a polypeptide chain containing 443 amino acids with the C-terminal human IgG1 Fc fragment. A fully biologically active molecule; rhB7-1(CD80) a molecular mass of 70 kDa analyzed by reducing SDS-PAGE and is obtained by chromatographic techniques at GenScript.